New COVID vaccine recommendations and how the coronavirus continues to evolve are discussed byStephen Thomas, MD.

Dr. Stephen Thomas, MD, is the Frank E. Young, MD, and Leanne Young Endowed Chair of Microbiology and Immunology and Director of the Global Health Institute at Upstate Medical University. An expert in infectious diseases and vaccine development, he is recognized globally for his leadership, research, and mentorship.

Hematologist/oncologistJade Homsi, MD, discusses how melanoma is diagnosed and the treatment options for this dangerous skin cancer. ResearcherKristopher Paolino, MD,tells about the study underway that tests a treatment strategy for people with chronic Lyme disease. GeriatricianSharon Brangman, MD,explains when someone may need to seek care from a geriatrics expert.

It’s not just Lyme Disease you have to watch out for. Two other tick-borne illnesses are quickly spreading in Central New York, and there’s a good chance you’ve never heard their names.

Today, the Global Grand Challenges (GC) network, a family of global partners fostering innovation to solve key global health and development problems, is announcing a group of 59 grant recipients who are developing ground-breaking solutions to address the impacts of climate change on health, agriculture, and gender equality in Africa, Asia, and the Americas.

U.S. Sen. Chuck Schumer, using the site of Upstate’sVector Biocontainment Laboratoryat the Institute of Human Performance on Tuesday, said pushed to surge funding for the CDC’s Vector-Borne Diseases programs, which includes EEEV and West Nile, with $65 million in new funding to stem the threat to communities from mosquito populations that spread disease.

We are pleased to share that all subjects in the prophylactic arm of the Phase 2a/b PROTECT clinical trial have received their initial dose of ISLA-101. They will be administered an attenuated strain of dengue fever on 4 October 2024, and we are just weeks away from understanding the potential impact of our drug ISLA-101…